18917 (2026). Hon Dr Ayesha Verrall to the Associate Minister of Health

Written Question

Published date: 24 May 2026

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	18917 (2026)
Question asked:	10 May 2026
Member asking:	Hon Dr Ayesha Verrall
Portfolio:	Associate Minister of Health
Minister replying:	Hon David Seymour
Answer received:	19 May 2026
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_18917_2026
Document guid:	0c95d152-982c-4e4b-bff7-b93463e388e2

18917 (2026). Hon Dr Ayesha Verrall to the Associate Minister of Health: Has acalabrutinib been funded by Pharmac for the treatment of relapsed or refractory mantle cell lymphoma; and if not, is it under consideration for funding?

Hon David Seymour: I am advised that Pharmac has not received an application for acalabrutinib for this indication, and therefore it is not currently under consideration for funding.